Laurion Capital Management LP Biogen Inc. Call Options Transaction History

Laurion Capital Management LP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $5.78 Million - $7.33 Million	-21,500 Reduced 51.81%	20,000 $6.33 Million
Q4 2019 Feb 13, 2020	SELL	$220.06 - $304.07 $23.2 Million - $32.1 Million	-105,500 Reduced 71.77%	41,500 $12.3 Million
Q3 2019 Nov 13, 2019	BUY	$217.44 - $243.88 $14.9 Million - $16.7 Million	68,600 Added 87.5%	147,000 $34.2 Million
Q2 2019 Aug 13, 2019	BUY	$219.29 - $241.72 $17.2 Million - $19 Million	78,400 New	78,400 $18.3 Million
Q1 2019 May 08, 2019	SELL	$216.71 - $338.96 $13.5 Million - $21.2 Million	-62,400 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $16.3 Million - $20.6 Million	58,500 Added 1500.0%	62,400 $18.8 Million
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $3.35 Million - $4.38 Million	-11,400 Reduced 74.51%	3,900 $1.38 Million
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $4.3 Million - $5.04 Million	15,300	15,300 $4.79 Million

1,035

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.